KMID : 1120320230090040137
|
|
Osteoporosis and Sarcopenia 2023 Volume.9 No. 4 p.137 ~ p.141
|
|
Effect of romosozumab in premenopausal women with severe osteoporosis and anorexia nervosa
|
|
Kazuki Fujimoto
Narumi Maki Daisuke Hashiba Toshifumi Maeyama Ryosuke Nakagawa Hajime Arai Seiji Ohtori
|
|
Abstract
|
|
|
Objectives: This study aims to investigate the effects of romosozumab on bone mineral density (BMD) and bone metabolism.
Methods: In this retrospective case series, romosozumab was administered to 5 premenopausal female patients with osteoporosis and anorexia nervosa with fragility fractures. BMD and bone turnover marker changes were investigated at 6 months and 1 year after administering romosozumab.
Results: BMD increased and high-turnover bone metabolism decreased 6 months and 1 year after administering romosozumab.
Conclusions: Romosozumab is useful for treating osteoporosis in patients with anorexia nervosa.
|
|
KEYWORD
|
|
Anorexia nervosa, Secondary osteoporosis, Anti-sclerostin antibody, Bone metabolism
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|